QIAGEN N.V. Conference Call on July 13 to Discuss Preliminary Q2 2021 Results

Rhea-AI Summary

QIAGEN N.V. (NYSE: QGEN) announced preliminary Q2 2021 results and updated its full-year outlook. A conference call is set for July 13, 2021, at 15:00 CET / 9:00 EDT, hosted by CEO Thierry Bernard and CFO Roland Sackers. Stakeholders can join by dialing +1 929 477 0402 (U.S.) or other regional numbers. The company continues to provide Sample to Insight solutions for over 500,000 customers globally across molecular diagnostics and life sciences sectors.

Positive

• Operating in a growing industry with a customer base of over 500,000.
• Leadership in Sample to Insight solutions, enhancing market position.

Negative

• None.

QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA) today has released preliminary Q2 2021 results and an updated outlook for full-year 2021.

A conference call is planned for Tuesday, July 13, 2021, at 15:00 CET / 9:00 EDT, hosted by Thierry Bernard, Chief Executive Officer, and Roland Sackers, Chief Financial Officer.

Conference call and webcast details

Interested parties may listen to the call by dialing:

+1 929 477 0402 (U.S.), +44 (0)330 336 9125 (UK), +49 (0) 69 2222 25574 (Germany).

To avoid waiting time, please join the event conference 5-10 minutes prior to the start time.
Conference ID: 7999995

The webcast will be accessible at:
https://globalmeet.webcasts.com/starthere.jsp?ei=1479747&tp_key=f5369b458c

A conference call replay will be available by using the following link:
https://globalmeet.webcasts.com/starthere.jsp?ei=1479747&tp_key=f5369b458c

Contact: IR@qiagen.com

About QIAGEN

QIAGEN N.V., a Netherlands-based holding company, is the leading global provider of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. Our sample technologies isolate and process DNA, RNA and proteins from blood, tissue and other materials. Assay technologies make these biomolecules visible and ready for analysis. Bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. Automation solutions tie these together in seamless and cost-effective workflows. QIAGEN provides solutions to more than 500,000 customers around the world in Molecular Diagnostics (human healthcare) and Life Sciences (academia, pharma R&D and industrial applications, primarily forensics). As of March 31, 2021, QIAGEN employed approximately 5,700 people in over 35 locations worldwide. Further information can be found at http://www.qiagen.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210712005636/en/

FAQ

What are the preliminary Q2 2021 results for QGEN?

QIAGEN N.V. has released its preliminary Q2 2021 results, but specific financial metrics were not detailed.

When is the QGEN conference call scheduled?

The QGEN conference call is scheduled for July 13, 2021, at 15:00 CET / 9:00 EDT.

Who will host the QGEN conference call?

The conference call will be hosted by CEO Thierry Bernard and CFO Roland Sackers.

How can I access the QGEN conference call?

You can access the QGEN conference call by dialing +1 929 477 0402 (U.S.) or other regional numbers provided.

What is the focus of QIAGEN's business?

QIAGEN focuses on providing Sample to Insight solutions, which help customers gain molecular insights from various samples.